Literature DB >> 6312874

Conversion of phospholipids to free fatty acids in response to acquisition of polymyxin resistance in Pseudomonas aeruginosa.

F R Champlin, H E Gilleland, R S Conrad.   

Abstract

The readily extractable lipids from a Pseudomonas aeruginosa isolate stepwise adapted to polymyxin resistance were compared with those of the susceptible parent and of a revertant strain which regained susceptibility. Significant qualitative and quantitative lipid alterations accompany the acquisition of resistance. Changes include the appearance of a major unidentified lipid (lipid X) unique to the readily extractable lipids of resistant cells. Comparative studies with parent and revertant strains indicated a significant decrease in the phospholipid content of resistant cells. Thin-layer chromatography of resistant-cell readily extractable lipids demonstrated: (i) the emergence of lipid X (36% of total readily extractable lipids), (ii) a decrease in phosphatidylethanolamine and phosphatidylglycerol, and (iii) an increase in diphosphatidylglycerol. Lipid X was purified by preparative silicic acid column chromatography and thin-layer chromatography and characterized by analytical thin-layer chromatography, column adsorption chromatography, and gas-liquid chromatography. Data from this study indicated that lipid X was a mixture of free fatty acids. The fatty acids present in lipid X were qualitatively and quantitatively the same as the fatty acids esterified to the phospholipids in the readily extractable lipids.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6312874      PMCID: PMC185095          DOI: 10.1128/AAC.24.1.5

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  21 in total

1.  Ultrastructural study of polymyxin-resistant isolates of Pseudomonas aeruginosa.

Authors:  H E Gilleland; R G Murray
Journal:  J Bacteriol       Date:  1976-01       Impact factor: 3.490

2.  Selective binding of polymyxin B to negatively charged lipid monolayers.

Authors:  M Teuber; I R Miller
Journal:  Biochim Biophys Acta       Date:  1977-06-16

3.  The effect of polymyxin B on outer membrane of Serratia marcescens: activation and dissociation of outer membrane associated alkaline phosphatase.

Authors:  J C Tsang; D M Kranz; D A Brown
Journal:  J Antibiot (Tokyo)       Date:  1977-03       Impact factor: 2.649

4.  In vivo activation by polymyxin B of phospholipase C from Pseudomonas aeruginosa.

Authors:  T Kusano; K Izaki; H Takahashi
Journal:  J Antibiot (Tokyo)       Date:  1977-10       Impact factor: 2.649

5.  Low magnesium and phospholipid content of cell wals of Pseudomonas aeruginosa resistant to polymyxin.

Authors:  M R Brown; W M Watkins
Journal:  Nature       Date:  1970-09-26       Impact factor: 49.962

6.  Relation between cation and lipid content of cell walls of Pseudomonas aeruginosa, Proteus vulgaris and Klebsiella aerogenes and their sensitivity to polymyxin B and other antibacterial agents.

Authors:  M R Brown; S M Wood
Journal:  J Pharm Pharmacol       Date:  1972-03       Impact factor: 3.765

Review 7.  The barrier function of the gram-negative envelope.

Authors:  L Leive
Journal:  Ann N Y Acad Sci       Date:  1974-05-10       Impact factor: 5.691

8.  Degradation of phospholipid in Pseudomonas aeruginosa induced by polymyxin B.

Authors:  T Kusano; K Izaki; H Takahashi
Journal:  J Antibiot (Tokyo)       Date:  1975-09       Impact factor: 2.649

9.  Ultrastructural and chemical alteration of the cell envelope of Pseudomonas aeruginosa, associated with resistance to ethylenediaminetetraacetate resulting from growth in a Mg2+-deficient medium.

Authors:  H E Gilleland; J D Stinnett; R G Eagon
Journal:  J Bacteriol       Date:  1974-01       Impact factor: 3.490

10.  Correlation of bacteria lipid composition with antibiotic resistance.

Authors:  J K Dunnick; W M O'Leary
Journal:  J Bacteriol       Date:  1970-03       Impact factor: 3.490

View more
  8 in total

Review 1.  Polymyxins revisited.

Authors:  David Landman; Claudiu Georgescu; Don Antonio Martin; John Quale
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

2.  Adaptive acquisition of novobiocin resistance in Pasteurella multocida strains of avian origin.

Authors:  M Arif; F R Champlin
Journal:  Vet Res Commun       Date:  1998-11       Impact factor: 2.459

3.  Susceptibility to hydrophobic molecules and phospholipid composition in Pasteurella multocida and Actinobacillus lignieresii.

Authors:  M E Hart; F R Champlin
Journal:  Antimicrob Agents Chemother       Date:  1988-09       Impact factor: 5.191

4.  In vitro synergy of colistin combinations against colistin-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae isolates.

Authors:  Céline Vidaillac; Lothaire Benichou; Raphaël E Duval
Journal:  Antimicrob Agents Chemother       Date:  2012-07-02       Impact factor: 5.191

5.  Fatty acid alterations and polymyxin B binding by lipopolysaccharides from Pseudomonas aeruginosa adapted to polymyxin B resistance.

Authors:  R S Conrad; C Galanos
Journal:  Antimicrob Agents Chemother       Date:  1989-10       Impact factor: 5.191

6.  Cell envelope phospholipid composition of Burkholderia multivorans.

Authors:  Sallie A Ruskoski; James W Bullard; Franklin R Champlin
Journal:  Curr Microbiol       Date:  2014-05-09       Impact factor: 2.188

7.  Evidence for two distinct mechanisms of resistance to polymyxin B in Pseudomonas aeruginosa.

Authors:  R A Moore; L Chan; R E Hancock
Journal:  Antimicrob Agents Chemother       Date:  1984-10       Impact factor: 5.191

8.  Integrating In Vitro and In Silico Analysis of a Cationic Antimicrobial Peptide Interaction with Model Membranes of Colistin-Resistant Pseudomonas aeruginosa Strains.

Authors:  Sandra Patricia Rivera-Sanchez; Iván Darío Ocampo-Ibáñez; Yamil Liscano; Natalia Martínez; Isamar Muñoz; Marcela Manrique-Moreno; Luis Martinez-Martinez; José Oñate-Garzon
Journal:  Pharmaceutics       Date:  2022-06-12       Impact factor: 6.525

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.